Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Bozorlar
Skriner
Yangiliklar
Biz haqimizda

NEOG - Neogen Corporation So'nggi Yangiliklar | Finranks

Home

NEOG

N

Neogen Corporation (NEOG)

NMS – Real vaqt narxi. Valyuta: USD

8.70

-0.45 (-4.92%)

Yopilishda: Mar 27, 2026, 4:00 PM EDT

8.70

0.00 (0.00%)

Bozordan keyin: Mar 27, 2026, 4:34 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

Neogen Announces Sale of Genomics Business to Zoetis

Neogen Announces Sale of Genomics Business to Zoetis

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today it has entered into a definitive agreement to sell its global genomics business to Zoetis Inc. (“Zoetis”), the world's leading animal health company, for $160 million, subject to customary closing adjustments. The planned divestiture, which had been previously announced, was part of the company's portfolio review strategy to simplify the business and focus on core s.

Neogen Corporation Could Re-Rate As 3M Food Safety Integration Improves

Neogen Corporation Could Re-Rate As 3M Food Safety Integration Improves

Neogen Corporation's sizeable $11 billion food-and-animal safety TAM still has secular tailwinds with regulation, traceability, and disease-prevention trends. Management believes this market has an overall projected 6%–7% CAGR through 2030. In that context, NEOG's Petrifilm anchors future recurring consumables and end-to-end testing ecosystem.

Animal Health Firm Neogen Initiates Recall Of Vials Over Microbial Contamination

Animal Health Firm Neogen Initiates Recall Of Vials Over Microbial Contamination

Neogen Corporation (NASDAQ: NEOG) on Wednesday initiated a voluntary nationwide recall of all unexpired lots of its Neogen Vet HYCOAT Hyaluronate Sodium Sterile Solution. The company identified microbial contamination in certain batches.

Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution

Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) is voluntarily recalling all lots within expiry of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution, for use in dogs, cats, and horses, to the veterinarian level. Neogen distributes this product, which is manufactured by a third-party supplier. This recall has been initiated due to microbial contamination in certain lots of 10 mL/50 mg product vials. Neogen received a number of reports of adverse events in horses following.

Neogen Corporation (NEOG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Neogen Corporation (NEOG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Neogen Corporation (NEOG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Neogen's Q2 Earnings and Revenues Beat Estimates, Stock Climbs

Neogen's Q2 Earnings and Revenues Beat Estimates, Stock Climbs

NEOG's Q2 EPS and revenues top estimates, sending shares up 31.6% as the company raises its fiscal 2026 revenue and EBITDA outlook.

Why Neogen Stock Blasted More Than 31% Higher Today

Why Neogen Stock Blasted More Than 31% Higher Today

The specialized healthcare company posted a beat-and-raise fiscal second quarter. Investors rushed into the stock, despite the fact that revenue and profitability were both down slightly year-over-year.

Videolar

No Data

There is no data to display

Press-relizlar

Neogen Announces Sale of Genomics Business to Zoetis

Neogen Announces Sale of Genomics Business to Zoetis

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today it has entered into a definitive agreement to sell its global genomics business to Zoetis Inc. (“Zoetis”), the world's leading animal health company, for $160 million, subject to customary closing adjustments. The planned divestiture, which had been previously announced, was part of the company's portfolio review strategy to simplify the business and focus on core s.

Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution

Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) is voluntarily recalling all lots within expiry of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution, for use in dogs, cats, and horses, to the veterinarian level. Neogen distributes this product, which is manufactured by a third-party supplier. This recall has been initiated due to microbial contamination in certain lots of 10 mL/50 mg product vials. Neogen received a number of reports of adverse events in horses following.

Neogen Announces Second-Quarter 2026 Results

Neogen Announces Second-Quarter 2026 Results

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) announced today the results of the second quarter ended November 30, 2025. “I am exceptionally proud of the Neogen team as we have initiated the first phase of our strategic transformation with early work focused on stabilizing and strengthening our core business. While it is early in the process, and our industry is currently seeing macro headwinds, our team drove significant sequential improvement in core revenue growth and pr.

Neogen® Announces Two Senior Leadership Appointments

Neogen® Announces Two Senior Leadership Appointments

LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) today announced the appointments of Joe Freels as Senior Vice President and Chief Commercial Officer, effective January 5, 2026, and Dr. Tammi Ranalli as Senior Vice President and General Manager, Global Food Safety, effective January 7, 2026. As Senior Vice President and General Manager for Neogen's Food Safety business unit, Dr. Ranalli will have full P&L responsibility for Neogen's global Food Safety portfolio and will de.